© 1997 American Heart Association, Inc.
Articles |
Diverse Effects of Heparin on Mitogen-Activated Protein Kinase–Dependent Signal Transduction in Vascular Smooth Muscle Cells
From the Department of Surgery, University of Washington, Seattle.
Correspondence to Dr Günter Daum, Department of Surgery, Box 356410, University of Washington, Seattle, WA 98195.
Abstract Proliferation of vascular smooth muscle cells (SMCs) is implicated in pathological events, including atherosclerosis and intimal hyperplasia following angioplasty. The glycosaminoglycan heparin is a growth inhibitor of SMCs in vitro and in vivo. The underlying mechanism, however, is still poorly understood. In the present study, we report that heparin inhibited the activation of the mitogen-activated protein kinase (MAPK) in baboon SMCs by serum but not by platelet-derived growth factor (PDGF). When fibroblast growth factor was used, heparin had a stimulatory effect on MAPK. The only MAPK-activating kinase found in SMCs was MAPK kinase (MAPKK)-1, although MAPKK-2 was present in comparable amounts. Activation of MAPKK-1 and DNA synthesis were affected by heparin in a similar fashion. Heparin does not appear to exert its effects through members of the protein kinase C family, which are downregulated by phorbol esters, because it was still capable of inhibiting MAPK/MAPKK-1 stimulation by FCS in phorbol ester–pretreated cells. The present findings support the conclusions that the effects of heparin depend on the nature of the mitogen and that heparin inhibits SMC proliferation by preventing activation of MAPKK-1.
Key Words: atherosclerosis • restenosis • proliferation • heparin • mitogen-activated protein kinase
This article has been cited by other articles:
 |
|
 |
|
  S. Fasciano, R. C. Patel, I. Handy, and C. V. Patel Regulation of Vascular Smooth Muscle Proliferation by Heparin: INHIBITION OF CYCLIN-DEPENDENT KINASE 2 ACTIVITY BY p27kip1 J. Biol. Chem., April 22, 2005; 280(16): 15682 - 15689. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. Xiao, Y. Liu, and D. M. Templeton Ca2+/calmodulin-dependent protein kinase II inhibition by heparin in mesangial cells Am J Physiol Renal Physiol, January 1, 2005; 288(1): F142 - F149. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. R. Newman, C.-M. Li, R. Simmons, J. Khosla, and P. L. Sannes Heparin affects signaling pathways stimulated by fibroblast growth factor-1 and -2 in type II cells Am J Physiol Lung Cell Mol Physiol, July 1, 2004; 287(1): L191 - L200. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Mishra-Gorur, H. A. Singer, and J. J. Castellot Jr Heparin Inhibits Phosphorylation and Autonomous Activity of Ca2+/Calmodulin-Dependent Protein Kinase II in Vascular Smooth Muscle Cells Am. J. Pathol., November 1, 2002; 161(5): 1893 - 1901. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. C. Patel, I. Handy, and C. V. Patel Contribution of Double-Stranded RNA-Activated Protein Kinase Toward Antiproliferative Actions of Heparin on Vascular Smooth Muscle Cells Arterioscler. Thromb. Vasc. Biol., September 1, 2002; 22(9): 1439 - 1444. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. M. Smorenburg and C. J. F. Van Noorden The Complex Effects of Heparins on Cancer Progression and Metastasis in Experimental Studies Pharmacol. Rev., March 1, 2001; 53(1): 93 - 106. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. G. Garg, B. T. Thompson, and C. A. Hales Structural determinants of antiproliferative activity of heparin on pulmonary artery smooth muscle cells Am J Physiol Lung Cell Mol Physiol, November 1, 2000; 279(5): L779 - L789. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Kalmes, B. R. Vesti, G. Daum, J. A. Abraham, and A. W. Clowes Heparin Blockade of Thrombin-Induced Smooth Muscle Cell Migration Involves Inhibition of Epidermal Growth Factor (EGF) Receptor Transactivation by Heparin-Binding EGF-Like Growth Factor Circ. Res., July 21, 2000; 87(2): 92 - 98. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. H. Thourani, S. S. Brar, T. P. Kennedy, L. R. Thornton, J. A. Watts, R. S. Ronson, Z.-Q. Zhao, A. L. Sturrock, J. R. Hoidal, and J. Vinten-Johansen Nonanticoagulant heparin inhibits NF-kappa B activation and attenuates myocardial reperfusion injury Am J Physiol Heart Circ Physiol, June 1, 2000; 278(6): H2084 - H2093. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. M Templeton, Y. Zhao, and M. Y. Fan Heterogeneity in the response of vascular smooth muscle to heparin: altered signaling in heparin-resistant cells Cardiovasc Res, January 14, 2000; 45(2): 503 - 512. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. R. Sindermann and K. L. March Heparin Responsiveness In Vitro as a Prognostic Tool for Vascular Graft Stenosis : A Tale of Two Cell Types? Circulation, June 30, 1998; 97(25): 2486 - 2490. [Full Text] [PDF]
|
|
|
|
|
|
J. D. Graves, K. E. Draves, Y. Gotoh, E. G. Krebs, and E. A. Clark Both Phosphorylation and Caspase-mediated Cleavage Contribute to Regulation of the Ste20-like Protein Kinase Mst1 during CD95/Fas-induced Apoptosis J. Biol. Chem., April 27, 2001; 276(18): 14909 - 14915. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. C. Woods, C. R. Blystone, J. Yoo, and E. R. Edelman Activation of EphB2 and Its Ligands Promotes Vascular Smooth Muscle Cell Proliferation J. Biol. Chem., January 11, 2002; 277(3): 1924 - 1927. [Abstract] [Full Text] [PDF]
|
|